Cloned (Comment) | Organism |
---|---|
gene Cers5, transient recombinant expression of His-tagged LASS5 in MLE cells | Mus musculus |
Protein Variants | Comment | Organism |
---|---|---|
additional information | LASS5 gene silencing by siRNAexogenously expressed LASS5 in lung epithelia is membrane-associated, triggering increased ceramide synthesis. Maximal inhibition is achieved when LASS5 is coexpressed with a plasmid encoding a neutral sphingomyelinase involved in sphingomyelin hydrolysis. Compared with control cells, cells transfected with LASS5 siRNA exhibit a 43% increase in rates of phosphatidylcholine synthesis | Mus musculus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
fumonisin B1 | knockdown using fumonisin B 1 reduces ceramide synthase activity by 78% | Mus musculus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
membrane | membrane-associated | Mus musculus | 16020 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | Q9D6K9 | - |
- |
Mus musculus C57BL/6 | Q9D6K9 | - |
- |
Purification (Comment) | Organism |
---|---|
recombinant His-tagged LASS5 from MLE cells by nickel affinity chromatography and ultrafiltration | Mus musculus |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
epithelium | - |
Mus musculus | - |
fibroblast | - |
Mus musculus | - |
lung | high enzyme expression level, pulmonary LASS5 is developmentally regulated, but its expression is spatially and gender-nonspecific | Mus musculus | - |
MLE-12 cell | mouse lung epithelial cell | Mus musculus | - |
additional information | in primary type II epithelial cells, murine lung fibroblasts, and MLE cells, LASS5 is the predominant ceramide synthase species identified | Mus musculus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
sphinganine + palmitoyl-CoA | - |
Mus musculus | N-palmitoylsphinganine + CoA | - |
? | |
sphinganine + palmitoyl-CoA | - |
Mus musculus C57BL/6 | N-palmitoylsphinganine + CoA | - |
? | |
sphingosine + palmitoyl-CoA | - |
Mus musculus | N-palmitoylsphingosine + CoA | - |
? | |
sphingosine + palmitoyl-CoA | - |
Mus musculus C57BL/6 | N-palmitoylsphingosine + CoA | - |
? |
Synonyms | Comment | Organism |
---|---|---|
ceramide synthase 5 | - |
Mus musculus |
CerS5 | - |
Mus musculus |
LASS5 | - |
Mus musculus |
longevity assurance homolog 5 | - |
Mus musculus |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Mus musculus |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.4 | - |
assay at | Mus musculus |
General Information | Comment | Organism |
---|---|---|
malfunction | knockdown using fumonisin B 1 or LASS5 small, interfering RNA reduced ceramide synthase activity by 78% or 45%, respectively. Exogenously expressed LASS5 in lung epithelia is membrane-associated, triggering increased ceramide synthesis. Compared with control cells, cells transfected with LASS5 siRNA exhibit a 43% increase in rates of phosphatidylcholine synthesis | Mus musculus |
metabolism | LASS5 expression alone reduces choline incorporation into phosphatidylcholine by 26%, whereas coexpression of LASS5 with sphingomyelinase produces a nearly 40% reduction in phosphatidylcholine synthesis | Mus musculus |
physiological function | LASS5 is the major ceramide synthase gene product involved in sphingolipid production that may also regulate PtdCho metabolism in pulmonary epithelia. LASS5 regulates surfactant phosphatidylcholine (PtdCho) synthesis | Mus musculus |